June 1, 2022

TB Alliance Names Pietro Turilli as Head of External Affairs

Executive brings more than 20 years in global partnerships and resource mobilization

May 3, 2022

TB Alliance Statement on New World Health Organization Rapid Communication on Key Changes to the Treatment of Drug-Resistant Tuberculosis

March 24, 2022

Advancing the Treatment of Drug-Resistant Tuberculosis this World TB Day

Imagining a TB-free world amidst resurgence during COVID-19 pandemic

March 11, 2022

Request for Proposals: Clinical Research Organization

February 2, 2022

TB Alliance Names Maria Beumont as Vice President, Chief Medical Officer for Research and Development

Executive brings more than 20 years of experience in pharmaceutical development

January 27, 2022

Shortfall in TB Research and Development Funding Persists as COVID-19 Erodes Hard-Won Gains

January 20, 2022

With tuberculosis resurgent after two years of COVID-19-inspired neglect, TB Alliance is awarded USAID funding to develop new treatments

January 13, 2022

Germany’s Federal Ministry of Education and Research (BMBF) Grants Additional Funding to Six PDPs Fighting Poverty-related and Neglected Tropical Diseases

December 15, 2021

TaBriX and The University of Manchester are working with TB Alliance to develop novel drugs to treat drug-resistant tuberculosis

November 23, 2021

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project